Not applicableStudy completedNCT05723068What this trial is testingBurden of Hepatitis D Virus (HDV) Infection in ItalyWho this might be right forChronic Hepatitis D University of Turin, Italy 515
Testing effectiveness (Phase 2)Study completedNCT05827146What this trial is testingStudy of Hepalatide in Chronic Hepatitis D(CHD) PatientsWho this might be right forChronic Hepatitis D Infection Shanghai HEP Pharmaceutical Co., Ltd. 23
Large-scale testing (Phase 3)Looking for participantsNCT07298330What this trial is testingA Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)Who this might be right forChronic Hepatitis D Infection Mirum Pharmaceuticals, Inc. 80
Not applicableApproved For MarketingNCT06780579What this trial is testingExpanded Access for BulevirtideWho this might be right forChronic Hepatitis Delta Virus Infection Gilead Sciences
Not applicableLooking for participantsNCT06122285What this trial is testingEffectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)Who this might be right forHepatitis D Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 100
Testing effectiveness (Phase 2)WithdrawnNCT02968641What this trial is testingLonafarnib With or Without Ritonavir in Patients With HDVWho this might be right forChronic Delta Hepatitis Eiger BioPharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00686790What this trial is testingEfficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)Who this might be right forHepatitis D, ChronicHepatitis B, Chronic Merck Sharp & Dohme LLC 68
Not applicableStudy completedNCT07116044What this trial is testingAssessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus InfectionWho this might be right forEvaluate Response to Treatment Both Biochemically and Virologically to Determine the Safety and Effectiveness of Bulevirtide Therapy in HDV Patients University of Molise 160
Testing effectiveness (Phase 2)WithdrawnNCT05953545What this trial is testingPeginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta HepatitisWho this might be right forChronic Hepatitis Delta National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableLooking for participantsNCT06504485What this trial is testingImmunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide TreatmentWho this might be right forHepatitis D Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 192
Testing effectiveness (Phase 2)Looking for participantsNCT07096193What this trial is testingStudy of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta VirusWho this might be right forChronic Hepatitis Delta Gilead Sciences 200
Not applicableActive Not RecruitingNCT06638320What this trial is testingHepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus InfectionWho this might be right forHepatitis Delta With Hepatitis B Carrier StateChronic Hepatitis b Tam Anh Research Institute 2,452
Large-scale testing (Phase 3)Study completedNCT01088659What this trial is testingPegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.Who this might be right forHepatitis D, Chronic Hoffmann-La Roche 50
Large-scale testing (Phase 3)Looking for participantsNCT07200908What this trial is testingA Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)Who this might be right forChronic Hepatitis D Infection Mirum Pharmaceuticals, Inc. 172
Post-approval studies (Phase 4)UnknownNCT00117533What this trial is testingPegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaWho this might be right forChronic Hepatitis BChronic Hepatitis D National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02637999What this trial is testingMyrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infectionWho this might be right forChronic Hepatitis D Infection Hepatera Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT07499544What this trial is testingA Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)Who this might be right forChronic Hepatitis D Infection Huahui Health 160
Large-scale testing (Phase 3)UnknownNCT05070364What this trial is testingPhase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDVWho this might be right forHepatitis Delta Virus Eiger BioPharmaceuticals 150
Not applicableNo Longer AvailableNCT05683548What this trial is testingReplicor Compassionate Access ProgramWho this might be right forViral Hepatitis BViral Hepatitis DCirrhosis, Liver+4 more Replicor Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT06649266What this trial is testingTrial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis DWho this might be right forChronic Hepatitis D Ribocure Pharmaceuticals AB 14